Literature DB >> 18313493

Fenofibrate and diabetic retinopathy.

Ning Cheung, T Y Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18313493     DOI： 10.1016/S0140-6736(08)60333-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Advances in the medical treatment of diabetic retinopathy.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 17.152

Review 2.  Current epidemiology of diabetic retinopathy and diabetic macular edema.

Authors:  Jie Ding; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

3.  Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.

Authors:  Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia Jenkins; Jonathan Shaw; Jie Jin Wang
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 4.  Systemic medical management of diabetic retinopathy.

Authors:  Gopal Lingam; Tien Yin Wong
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

Review 5.  Should we start all patients with diabetic retinopathy on fenofibrates?

Authors:  Jacob Koshy; Jency M Koshy; Satish Thomas; Gurvinder Kaur; Thomas Mathew
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

6.  Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema.

Authors:  Srilakshmi Srinivasan; Prathibha Hande; Jyoti Shetty; Sindhu Murali
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.